Status:
UNKNOWN
Sleeve Gastrectomy Versus One-anastomosis Gastric Bypass: Randomized Trial
Lead Sponsor:
Mansoura University
Conditions:
Morbid Obesity
Eligibility:
All Genders
16-70 years
Phase:
NA
Brief Summary
Hormonal changes after SG and OAGB involve alterations in the levels of many enteric hormones, among these hormones are ghrelin and glucagon-like peptide-1 (GLP-1). Ghrelin is an orexigenic hormone th...
Eligibility Criteria
Inclusion
- Adult patients of both genders with morbid obesity (defined as BMI \> 40 kg/m2 or \> 35 Kg/m2 with at least one associated comorbidity) were included. Patients who underwent previous surgery for morbid obesity were also included.
Exclusion
- patients ageing more than 60 years
- patients with endocrine disorders
- patients with psychiatric disorders that influence perception of the study protocol
- patients unfit for general anesthesia.
Key Trial Info
Start Date :
March 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04134156
Start Date
March 1 2016
End Date
November 1 2019
Last Update
October 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura university hospital
Al Mansurah, Dakahlia Governorate, Egypt, 35516